2023 annual financial data
Shuttle Pharmaceuticals Holdings 2023 Operating income growth
Direct answer
Operating income growth was -151.4%.
Operating income was -5,892,382 USD and net income was -6,592,723 USD.
Operating cash flow was -5,581,147 USD.
Get free Shuttle Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,892,382 USD
- Net income
- -6,592,723 USD
- Operating cash flow
- -5,581,147 USD